Skip to content
DataLookout
Menu

NCT07877727

Empowering the Clinical Management of BMFs Through a Biological and Genetically Driven Pediatric and Adult National Network

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Study completion pushed from Dec 31, 2026 to Feb 28, 2027
    • Site details revised at 1 of 4 sites
    • Study title shortened, about 2 words
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Early Diagnosis and Molecular Characterization of CMF and AAA
Timeframe: Within the 24-month project period

Arms and interventions

Fanconi anemia (FA)

Fanconi anemia (FA)

Dyskeratosis congenita (DC) e altri telomere biology disorders (TBD)

Dyskeratosis congenita (DC) e altri telomere biology disorders (TBD)

Congenital neutropenia (CN)

Congenital neutropenia (CN)

Primary immune regulatory disorders (PIRD)

Primary immune regulatory disorders (PIRD)

Congenital amegakaryocytic thrombocytopenia (CAMT)

Congenital amegakaryocytic thrombocytopenia (CAMT)

Acquired aplastic anemia (AAA), with or without paroxysmal nocturnal hemoglobinuria (PNH)

Acquired aplastic anemia (AAA), with or without paroxysmal nocturnal hemoglobinuria (PNH)

Sites

4 sites in 1 country